Results 171 to 180 of about 201,939 (281)

Performance of ResNet‐18 and InceptionResNetV2 in Automated Detection of Diabetic Retinopathy

open access: yesMedicine Advances, EarlyView.
This study compares ResNet‐18 and InceptionResNetV2 for automated diabetic retinopathy (DR) classification using retinal fundus images. ResNet‐18 achieved a test accuracy of 83% and an AUC of 94.6%, demonstrating robust generalization across all DR stages.
Akwasi Asare   +4 more
wiley   +1 more source

Interstitial Cystitis/Bladder Pain Syndrome in Men

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims In April 2025, the Wake Forest Institute for Regenerative Medicine hosted a Global Consensus meeting on interstitial cystitis/bladder pain syndrome (IC/BPS) in Winston‐Salem, NC. The goal of this meeting was to establish attainable targets in phenotyping, diagnosis, and biomarkers for IC/BPS.
Madeline Snipes   +5 more
wiley   +1 more source

Pituitary ablation for diabetic retinopathy. [PDF]

open access: bronze, 1970
J. S. Speakman   +5 more
openalex   +1 more source

Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Methods A systematic review of CINAHL, Cochrane Library, PubMed, and SCOPUS databases was conducted according to PRISMA guidelines to identify studies evaluating T2DM and hearing loss. Primary outcome measures included continuous measures (mean), proportions (%), proportional difference (∆), and relative risks (RR) with 95% confidence ...
Cory Hyun‐su Kim   +6 more
wiley   +1 more source

Retinopathy of Prematurity [PDF]

open access: bronze, 1971
Alec Garner, Nicholas J. Ashton
openalex   +1 more source

Complications at Diagnosis of Pediatric Chronic Myeloid Leukemia in Chronic Phase

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Chronic myeloid leukemia (CML) is uncommon during the first two decades of life, resulting in limited experience of pediatricians in handling this leukemia. This is even more true when it comes to managing rare complications at the time of diagnosis.
Nirmalya Roy Moulik   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy